1 – 10 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Anti-phospholipid antibodies and renal involvement are the main features associated with adverse pregnancy outcomes in patients with Systemic Lupus Erythematosus. A long-term longitudinal study in Southern Sweden
- Autoantibody and cytokine profiles during treatment with belimumab in patients with systemic lupus erythematosus
-
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus
Linge, Petrus LU ; Arve, Sabine LU
;
Olsson, Lina M.
;
Leonard, Dag
;
Sjöwall, Christopher
;
Frodlund, Martina
;
Gunnarsson, Iva
;
Svenungsson, Elisabet
;
Tydén, Helena
LU
and
Jönsen, Andreas
LU
, et al.
(2020)
In Annals of the Rheumatic Diseases
79(2).
p.254-261
Mark
- High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
- Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus : A multi-center observational study
- Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
- 2019
- Low Production of Reactive Oxygen Species Drives Systemic Lupus Erythematosus
- Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
- Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus
- Sex differences in clinical presentation of systemic lupus erythematosus